Results 121 to 130 of about 11,081 (214)

Investigation of Orlistat as an intervention for obesity and cardiovascular risk factors: A systematic review [PDF]

, 2010
Background – Obesity is an ever increasing problem in modern society. Numerous pharmacological interventions have been introduced to combat the detrimental effects of this major health issue, including the lipase inhibitor, orlistat.
Wrigley, Daniel K.
core  

Orlistat : Lösningen på problemet med övervikt

, 2015
Bakgrund Övervikt och överviktsrelaterade sjukdomar är idag ett globalt problem som är vanligt bland alla åldersgrupper och bland alla etniciteter. Övervikt kan ha många orsaker, men den huvudsakliga orsaken är att intaget av energi är större än den ...
Truedsson, Josefine
core   +1 more source

Pharmacodynamic testing and new validated HPLC method to assess the interchangeability between multi-source orlistat capsules

Drug Design, Development and Therapy, 2017
Abdel Naser Zaid,1 Nihal Zohud,1 Bushra E’layan,1 Tasneem Aburadi,1 Nidal Jaradat,1 Iyad Ali,2 Fatima Hussein,1 Mashhour Ghanem,3 Aiman Qaddomi,3 Yara Abu Zaaror4 1Department of Pharmacy, 2Department of Biomedical Sciences, Faculty of Medicine and
Zaid AN, Zohud N, E'layan B, Aburadi T, Jaradat N, Ali I, Hussein F, Ghanem M, Qaddomi A, Abu Zaaror Y   +9 more
doaj  

Lack of interaction between orlistat and oral contraceptives

, 1996
Objectives: Orlistat, a potent and selective inhibitor of gastrointestinal lipases, is designed for the treatment of obesity. A double-blind, randomised, placebo-controlled, 2-way crossover study investigated the possible influence of orlistat on the ...
Hartmann, D., Odink, J., Güzelhan, C., Zuiderwijk, P.B.M.   +3 more
core  

A novel bile salt hydrolase-producing <i>Ligilactobacillus salivarius</i> prevents diet-induced obesity via regulation of bile acid metabolism and glucagon-like peptide 1 restoration. [PDF]

Gut Microbes
Lv J, Zhou L, Dai X, Landberg R, Meng H, Tian H, Zhang S, Liu T, Yin X, Zhang J, Song X, Bonny C, Blum S, Cao Y, Guo J, Peng W, Tan Y, Shi L.   +17 more
europepmc   +1 more source

Phytochemical profiling and anti-obesity potential of the methanol extract of <i>Carica papaya</i> ripe fruit peel. [PDF]

Avicenna J Phytomed
Ahsan R, Ashiq K, Shah SA, Ahsan MZ, Shafiullah, Ashraf M, Bukhari I.   +6 more
europepmc   +1 more source

Long-Term Effects of Orlistat on Lipid Metabolism and Anthropometric Indices: A Meta-Analysis of Clinical Trials. [PDF]

J Obes
Khodadadiyan A, Khazraei Y, Kamali M, Kolaei K, Aminzadeh P, Yazdanpanah G, Shams A, Feili M, Ghaffari M, Hosseini M, Bazrafshan M, Drissi HB, Arzhangzadeh A.   +12 more
europepmc   +1 more source

ORLISTAT EN SUJETOS MEXICANOS. ENSAYO CLÍNICO COMPARATIVO DE EFECTIVIDAD TERAPÉUTICA

, 2011
El objetivo fue determinar si en sujetos mexicanos con sobrepeso u obesidad el orlistat a dosis de 60mg versus orlistat 120 mg vía oral, conserva la misma eficacia terapéutica y los eventos adversos gastrointestinales esperados son mejor tolerados ...
Ávila-Campos, José Alejandro, López-Alonzo, Salvador Jesús, Sanín-Aguirre, Luz Helena, Díaz-López, Carla Verónica, Velázquez-Quintana, Merced   +4 more
core  

Effect of orlistat and anti-androgen oral contraceptives on pregnancy outcomes in overweight or obese PCOS patients during comprehensive management. [PDF]

Arch Gynecol Obstet
Zhang M, Ruan X, Jiang L, Li Y, Wang Z, Li Y, Liu A, Mueck AO.   +7 more
europepmc   +1 more source

Effects of orlistat on APRI and FIB-4 scores in patients with obesity: a retrospective observational study. [PDF]

BMC Endocr Disord
Durantas H, Boz O, Unver CK, Fedai NK, Cakal B, Hepsen S, Cakal E.   +6 more
europepmc   +1 more source